• DHIS2 a créé une nouvelle discussion

    The HISP Centre at University of Oslo invites you to join us for this quarter’s Gavi-supported DHIS2 for Immunization webinar, which focuses on leveraging DHIS2 for new and emerging vaccine deliveries. As of October 2023, WHO recommends the programmatic use of malaria vaccines for the prevention of P. falciparum malaria in children living in malaria-endemic areas, prioritizing areas of moderate and high transmission.

    This webinar will feature real implementation examples demonstrating how countries are approaching these new activities and integrating the new components into their DHIS2-based Expanded Program on Immunization (EPI) programs and DHIS2 national Health Management Information Systems (HMIS) platforms.

    This webinar will be conducted in English and French:

    We hope that you are able to join us for this online event!

    Max Krafft
    Lead, DHIS2 Training & Communication group
    HISP…

    The HISP Centre at University of Oslo invites you to join us for this quarter’s Gavi-supported DHIS2 for Immunization webinar, which focuses on leveraging DHIS2 for new and emerging vaccine deliveries. As of October 2023, WHO recommends the programmatic use of malaria vaccines for the prevention of P. falciparum malaria in children living in malaria-endemic areas, prioritizing areas of moderate and high transmission.

    This webinar will feature real implementation examples demonstrating how countries are approaching these new activities and integrating the new components into their DHIS2-based Expanded Program on Immunization (EPI) programs and DHIS2 national Health Management Information Systems (HMIS) platforms.

    This webinar will be conducted in English and French:

    We hope that you are able to join us for this online event!

    Max Krafft
    Lead, DHIS2 Training & Communication group
    HISP Centre
    University of Oslo
    dhis2.org | hisp.uio.no

    Lire la suite
    1. View Post
    0
    Comments (0)
    Publication en cours de modération
    Statut publié avec succès. Il est désormais visible dans votre journal.
Impossible de charger le contenu de l'info-bulle.